GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Market Cap

Instadose Pharma (Instadose Pharma) Market Cap : $0.59 Mil (As of May. 20, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Instadose Pharma's share price for the quarter that ended in Feb. 2022 was $6. Instadose Pharma's Shares Outstanding (EOP) for the quarter that ended in Feb. 2022 was 531.93 Mil. Therefore, Instadose Pharma's market cap for the quarter that ended in Feb. 2022 was $3,191.60 Mil.

Instadose Pharma's quarterly market cap increased from Aug. 2021 ($262.50 Mil) to Nov. 2021 ($1,845.82 Mil) and increased from Nov. 2021 ($1,845.82 Mil) to Feb. 2022 ($3,191.60 Mil).

Instadose Pharma's annual market cap increased from Nov. 2019 ($0.00 Mil) to Nov. 2020 ($7.50 Mil) and increased from Nov. 2020 ($7.50 Mil) to Nov. 2021 ($1,845.82 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Instadose Pharma's Enterprise Value for Today is $0.76 Mil.


Instadose Pharma Market Cap Historical Data

The historical data trend for Instadose Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Market Cap Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
Market Cap
Get a 7-Day Free Trial - - - 7.50 1,845.82

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.39 7.39 262.50 1,845.82 3,191.60

Competitive Comparison of Instadose Pharma's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instadose Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Market Cap falls into.



Instadose Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Instadose Pharma's Market Cap for the fiscal year that ended in Nov. 2021 is calculated as

Market Cap (A: Nov. 2021 )=Share Price (A: Nov. 2021 )*Shares Outstanding (EOP) (A: Nov. 2021 )
=$24.61*75.003
=$1,845.82

Instadose Pharma's Market Cap for the quarter that ended in Feb. 2022 is calculated as

Market Cap (Q: Feb. 2022 )=Share Price (Q: Feb. 2022 )*Shares Outstanding (EOP) (Q: Feb. 2022 )
=$6*531.934
=$3,191.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instadose Pharma  (OTCPK:INSD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Instadose Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus